August - 20206August - 03 - 2020, volume 04 - Issue 12 (ISSN 2691-4093) Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerDavid JohnJaxon JaseSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Contact usEmailPhone:510 230 0396 Fax:510-894-8405sales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to Medical Tech OutlookVisit www.medicaltechoutlook.com Copyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comFor the in vitro diagnostics landscape, 2020 so far has been a year for the development of more simplified diagnostic test kits. With the beginning of a new decade, the industry is all set to undertake strategic initiatives such as investing in novel technologies like IoT and AI for faster and innovative production of non-invasive test kits and tools.Alongside, the industry will also expand into new domains and develop new products through collaborations, mergers, and acquisitions to gain a larger market share and widen the product portfolio. Especially, infectious diseases like tuberculosis and hepatitis will witness a greater utilization and application of in vitro technologies. That being said, several pieces of market research are also directing toward an inclusive future of in vitro diagnostics, based on the continually growing end-users, applications, technology, and products and service.In this edition of MedTech Outlook, we bring you the story of some of the most successful in-vitro diagnostic solution providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts with real-life stories on fostering robust partnerships and exclusive insights from CXOs. We hope this edition will provide you with the right assistance in choosing the best in-vitro solution providers according to your requirements. Let us know your thoughts!The New Era of AI-Driven In Vitro DiagnosisSarah FernandesEDITORIAL
< Page 5 | Page 7 >